VJET Flyte Aviation, Inc.
Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 1716621 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY599.8%
TTM net income YoY-51.9%
TTM EPS YoY89.8%
Revenue 3-yr CAGR124.0%
Net income 3-yr CAGR—
Margins
Gross margin29.2%
Operating margin-527.1%
Net margin-733.4%
FCF margin-331.6%
EBITDA margin-499.9%
Returns
ROE-273.6%
ROA-104.1%
ROIC (approx.)-173.4%
Asset turnover0.14x
Leverage & solvency
Liabilities / assets51.7%
Debt / equity0.00x
Current ratio0.54x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.45x
Accruals ratio-57.1%
Payout ratio—
Capex / revenue0.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $819,000 | $420,000 | $442,000 | $14,000 | $22,000 |
| Cost of revenue | $63,000 | $42,000 | $30,000 | $161,000 | $1.56M |
| Gross profit | $756,000 | $378,000 | $412,000 | -$147,000 | -$1.54M |
| R&D expense | $862,000 | $272,000 | $475,000 | $6.39M | $12.25M |
| SG&A expense | $12.07M | $11.35M | $17.12M | $16.25M | $15.47M |
| Operating income | -$21.14M | -$11.24M | -$78.12M | -$26.96M | -$29.27M |
| Pretax income | -$19.50M | -$13.50M | -$70.57M | -$26.86M | -$27.26M |
| Income tax | -$1.81M | $3.14M | $0 | $3,000 | $4,000 |
| Net income | -$17.18M | -$16.64M | -$70.57M | -$26.86M | -$25.07M |
| EBITDA | -$19.03M | -$9.13M | -$76.04M | -$26.54M | -$27.70M |
| EPS (basic) | -15.90 | -126.91 | -129.88 | -25.98 | -248.22 |
| EPS (diluted) | — | — | — | -25.98 | -248.22 |
| Weighted avg. shares (diluted) | — | — | — | 1.03M | 101,000 |
| Balance sheet | |||||
| Cash & equivalents | $88,000 | $2.87M | $3.56M | $15.86M | $15.04M |
| Short-term investments | $0 | — | — | — | — |
| Receivables | $155,000 | $70,000 | $137,000 | $0 | $21,000 |
| Inventory | $86,000 | $33,000 | $44,000 | $0 | $986,000 |
| Current assets | $390,000 | $3.29M | $4.16M | $16.84M | $17.09M |
| PP&E, net | $0 | $91,000 | $70,000 | $0 | $1.81M |
| Goodwill | $0 | — | $0 | $0 | — |
| Intangibles | $0 | $24.27M | $26.32M | $0 | — |
| Total assets | $15.86M | $27.77M | $30.74M | $16.84M | $21.04M |
| Current liabilities | $3.91M | $2.23M | $2.47M | $7.58M | $5.39M |
| Short-term debt | $0 | — | — | — | — |
| Long-term debt | $3.08M | — | — | — | — |
| Total debt | $3.08M | — | — | — | — |
| Total liabilities | $9.21M | $16.01M | $9.54M | $7.58M | $7.37M |
| Shareholders' equity | $7.05M | $11.76M | $21.19M | $9.26M | $13.67M |
| Net debt | $2.99M | — | — | — | — |
| Shares outstanding | 173,896 | 421,296 | 702,662 | 2.16M | 140,000 |
| Cash flow statement | |||||
| Operating cash flow | -$8.30M | -$9.27M | -$20.62M | -$22.57M | -$27.62M |
| Capital expenditure | $17,000 | $67,000 | $76,000 | $17,000 | $265,000 |
| Free cash flow | -$8.31M | -$9.34M | -$20.70M | -$22.59M | -$27.89M |
| Investing cash flow | $167,000 | -$67,000 | -$61,000 | $21,000 | $3.80M |
| Financing cash flow | $5.34M | $8.65M | $8.39M | $23.36M | $14.96M |
| Depreciation & amortization | $2.12M | $2.11M | $2.08M | $421,000 | $1.56M |
| Stock-based compensation | $338,000 | $54,000 | $1.22M | $447,000 | $2.24M |
Free plan shows the latest 5 periods; Pro shows all 9 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.